Susquehanna International Group’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,808,500
| Closed | -$180M | – | 11307 |
|
|
2019
Q3 | $180M | Sell |
1,808,500
-1,079,800
| -37% | -$103M | 0.06% | 265 |
|
|
2019
Q2 | $267M | Sell |
2,888,300
-3,197,500
| -53% | -$304M | 0.1% | 170 |
|
|
2019
Q1 | $574M | Buy |
6,085,800
+804,800
| +15% | +$70.4M | 0.24% | 60 |
|
|
2018
Q4 | $338M | Buy |
5,281,000
+244,400
| +5% | +$18M | 0.13% | 119 |
|
|
2018
Q3 | $451M | Sell |
5,036,600
-1,977,900
| -28% | -$175M | 0.15% | 93 |
|
|
2018
Q2 | $557M | Buy |
7,014,500
+1,898,400
| +37% | +$158M | 0.19% | 67 |
|
|
2018
Q1 | $456M | Buy |
5,116,100
+168,300
| +3% | +$16.2M | 0.16% | 83 |
|
|
2017
Q4 | $516M | Buy |
4,947,800
+1,280,600
| +35% | +$144M | 0.18% | 73 |
|
|
2017
Q3 | $535M | Buy |
3,667,200
+163,200
| +5% | +$22.2M | 0.21% | 67 |
|
|
2017
Q2 | $455M | Buy |
3,504,000
+247,400
| +8% | +$30.3M | 0.2% | 81 |
|
|
2017
Q1 | $405M | Buy |
3,256,600
+220,800
| +7% | +$26.4M | 0.21% | 76 |
|
|
2016
Q4 | $351M | Buy |
3,035,800
+250,900
| +9% | +$27.9M | 0.18% | 89 |
|
|
2016
Q3 | $291M | Sell |
2,784,900
-1,290,600
| -32% | -$140M | 0.14% | 109 |
|
|
2016
Q2 | $402M | Buy |
4,075,500
+784,300
| +24% | +$81.1M | 0.22% | 69 |
|
|
2016
Q1 | $329M | Sell |
3,291,200
-769,700
| -19% | -$79.3M | 0.18% | 88 |
|
|
2015
Q4 | $486M | Sell |
4,060,900
-538,600
| -12% | -$62.3M | 0.22% | 66 |
|
|
2015
Q3 | $498M | Buy |
4,599,500
+1,225,400
| +36% | +$152M | 0.22% | 68 |
|
|
2015
Q2 | $391M | Sell |
3,374,100
-1,743,800
| -34% | -$199M | 0.17% | 86 |
|
|
2015
Q1 | $590M | Buy |
5,117,900
+553,500
| +12% | +$66.1M | 0.27% | 41 |
|
|
2014
Q4 | $511M | Buy |
4,564,400
+816,000
| +22% | +$86.1M | 0.2% | 72 |
|
|
2014
Q3 | $355M | Sell |
3,748,400
-1,199,500
| -24% | -$108M | 0.14% | 110 |
|
|
2014
Q2 | $425M | Buy |
4,947,900
+75,700
| +2% | +$5.76M | 0.18% | 74 |
|
|
2014
Q1 | $340M | Sell |
4,872,200
-200,400
| -4% | -$15.9M | 0.16% | 93 |
|
|
2013
Q4 | $429M | Buy |
5,072,600
+1,497,200
| +42% | +$118M | 0.2% | 68 |
|
|
2013
Q3 | $275M | Sell |
3,575,400
-102,000
| -3% | -$7.15M | 0.15% | 90 |
|
|
2013
Q2 | $215M | Buy |
+3,677,400
| New | +$221M | 0.12% | 111 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Susquehanna International Group's CELG Position: Q4 2019 in Review
Susquehanna International Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,651,500 shares — an estimated $164M sold.
Susquehanna International Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $353M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Susquehanna International Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Susquehanna International Group sold 1,651,500 Celgene Corp shares in Q4 2019, an estimated $164M.
- Susquehanna International Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Susquehanna International Group's Celgene Corp position peaked at $353M in Q1 2018.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.